FDA.reportPublic FDA data

Application 210039

Type
ANDA
Sponsor
AMNEAL PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CLOBAZAMCLOBAZAMSUSPENSION;ORAL2.5MG/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69238-1535ClobazamClobazamAmneal Pharmaceuticals NY LLCANDACurrent
69238-1535ClobazamClobazamAmneal Pharmaceuticals NY LLCANDACurrent
69238-1535ClobazamClobazamAmneal Pharmaceuticals NY LLCANDACurrent
69238-1535ClobazamClobazamAmneal Pharmaceuticals NY LLCANDACurrent
69238-1535ClobazamClobazamAmneal Pharmaceuticals LLCANDACurrent
69238-1535ClobazamClobazamAmneal Pharmaceuticals NY LLCANDACurrent